Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Former KV Pharmaceutical CEO Sentenced To 30 Days In Jail

This article was originally published in The Pink Sheet Daily

Executive Summary

Marc Hermelin pleads guilty to distributing oversized morphine sulfate tablets; he may be first pharma exec to be jailed for healthcare fraud.
Advertisement

Related Content

Acquittal Of Ex-GSK Lawyer Unlikely To Deter Government Prosecution Of Execs
Former InterMune CEO Sentenced To Probation, DoJ Reindicts Former GSK Attorney
"Any Little Opening": Whistleblowers Target New Kinds Of Pharma Conduct
Makena Pricing Raises Ire Of Maternal Health Advocacy Groups
FDA Prosecution Criteria For “Responsible” Execs Includes Seriousness, Obviousness Of Violations
Still Guilty: Three Former Purdue Execs Lose Fight To Overturn Their Exclusion From Gov't Programs
KV Official Is Excluded From Government Programs, The First Under OIG's New Guidance
KV Official Is Excluded From Government Programs, The First Under OIG's New Guidance
KV Pharmaceutical To Decide Whether To Retain Generics Business After Settling Manufacturing Cover-up Charges With DoJ
Legal Briefs: September Is a Mixed Bag For Brand Pharma Patents

Topics

Advertisement
UsernamePublicRestriction

Register

PS071933

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel